AS may occur in isolation, or in association with other congenital cardiac defects. These include other left heart obstructive lesions in Shone association and the hypoplastic left heart syndrome (HLHS) as well as septal defects. It may also occur with extra-cardiac malformations of the renal, gastrointestinal and central nervous systems.
INTRODUCTION
Severe or critical aortic stenosis (AS) in the neonate represents a cardiac emergency. Unless the diagnosis is made in utero or at delivery, the baby may be discharged home presenting later in extremis when the ductus arteriosus (DA) closes. Management of severe AS is aimed at quickly, safely and adequately reducing the severity of the left ventricular outflow tract obstruction (LVOTO) whilst maintaining the greatest degree of aortic valve integrity and left ventricular function.
BACKGROUND
Congenital AS comprises 5% of congenital heart defects, with incidences ranging from 0.04 to 0.38 per 1 000 live births. (1, 2) There is a clear male predominance with a male to female ratio of 4:1.
The transmission risk is greater if the affected parent is the mother (recurrence risk ~3% and ~15% in children of an affected father or mother respectively). This defect occurs sporadically in most cases.
There is an association with Turner Syndrome (45XO) and rarely in William Syndrome (7q11 del). Autosomal dominant inheritance may be associated with mutations in the NOTCH1 gene. Summer 2014
Volume 11 • Number 1 cushions also transform histologically from a primitive myosin-heavy chain to an alpha-smooth muscle actin phenotype: the mature semi-lunar valve leaflets, which are thinner and more pliable.
Many of the pathways involved in the formation of the semi-lunar valves, especially the role of mesenchymal transformation, are still being explored. Correct valve formation requires proliferation of endocardial cushion tissue, yet this must also be limited to ensure that the cushions can be remodelled to form thin cusps. Congenital abnormalities of the aortic valve such as bicuspid, unicuspid and dysplastic valves are thus thought to be the result of failure of the truncoconal neural crest tissue migration, of incorrect fusion and/or of incomplete transformation and differentiation of the endocardial cushions. (6, 7) PATHOLOGY Aortic valves may be morphologically unicuspid (functionally or true), bicuspid (functionally or true), tricuspid (normal) (Figure 3) or rarely quadricuspid. (8) Bicuspid aortic valves (BAV) are common and occur in 0.5 -2% of the population with a 2:1 male predominance. (9) The incidence may be as high as 10% in some families. An exact inheritance pattern has yet to be determined. Currently, it is thought that bicuspid valves are due to the interaction of multiple genes causing abnormal root structure. (10) BAV may occur in isolation or in association with patent ductus arteriosus (PDA), coarctation of the aorta, Williams syndrome (rare) and Turner syndrome. Animal studies have demonstrated a complex interaction between intracellular pathways and individual stem cells rather than just faulty fusion of cusps. (5) Various forms of BAV have been described with the anterior-posterior formation being the most common. (11, 12) BAV can develop stenosis and/or incompetence, as well as ascending aorta aneurysms and dissections. (13) Only a quarter of patients will have normal valve function and will require no intervention. (14, 15) Unicuspid aortic valves (UAV) are less common and occur in only approximately 1 of 10 000 population. (16) They are associated with significant aortic stenosis. An estimated 50% of individuals with UAV also have dilation of the ascending aorta. (17) All valves have a single posterior commissural attachment. The free edge of the valve extends from the single commissure without further connection to the aorta.
Quadricuspid aortic valves (QAV) are rare, occurring in only 1-10 patients per 100 000 population, with a slight male predominance. (18) This condition was first described by Balington in 1862
and can affect both the pulmonary and aortic valves in a 10:1 ratio. (19) Unlike BAV, aortic stenosis is rare. Significant aortic valve incompetence, secondary to a central malcoaptation of the 4 valve leaflets, is commonly observed in QAV.
In the severely dysplastic valve, no normal valve leaflets or anatomy may be distinguishable. Balloon dilation of the aortic valve in this situation, even with a high-pressure, non-compliant balloon, is seldom successful. The valve tissue recoils back to its original position once the balloon is deflated. Open surgical valvotomy with debulking of the leaflets has a far better outcome for this subset of patients. (20, 35) 
MANAGEMENT
The aim of all AS treatment is to preserve the function of the aortic valve and the left ventricle for as long as possible.
Medical management
Neonates with severe or critical AS have decreased cardiac output and need urgent haemodynamic support. Resuscitation with fluids and a continuous infusion of alprostadil at a dose of 0.01-0.1mcg/ kg/min IVI must be started without delay. Alprostadil produces vasodilation of the DA smooth muscle and increases cardiac output.
Opening and maintaining the patency of the DA will ensure adequate systemic blood flow and perfusion of the vital organs. The infant should be monitored for side-effects, specifically apnoea episodes (12%). Apnoea is seen most often in neonates with a low birth weight <2kg, at higher dosages and usually appears during the first hour of administration. Other adverse effects include: fever (14%), bradycardia (7%), hypotension (4%), seizures (4%), tachycardia (3%), diarrhoea (2%) and sepsis (2%). Hypokalemia and cardiac arrest occur in <1% of patients. Once stabilised, the infant should be referred for urgent intervention to reduce the severity of the LVOTO.
Interventional management
The stenosis of the aortic valve may be addressed by either balloon valvuloplasty (BV) or surgical valvotomy (SV). In recent years a third alternative, hybrid intervention, has emerged as a palliative measure for infants with borderline hypoplastic left heart dimensions. This entails balloon atrial septostomy with stenting of the PDA by the paediatric cardiologist with pulmonary artery banding by the cardiothoracic surgeon.
The choice of treatment should be guided by evidence-based reviews; local experience and skills. It is usually dictated by the morphology of the aortic valve, the size and function of the left heart, the presence of associated defects and the overall condition and weight of the neonate. The key issue is to decide whether the left heart structures are adequate to sustain the systemic circulation, i.e. a biventricular repair, (22) and if so, what intervention will be the most beneficial for the individual neonate. (23, 24) The pros and cons of each intervention have been the subject of many publications. (25, 26, 27, 28, 29, 30) Many studies have been published comparing the results of SV vs.
BV for severe congenital AS. Outcomes such as longterm survival, incidence of aortic valve re-stenosis, residual stenosis or insufficiency (or both), freedom from re-operation and death or need for transplantation have been compared.
Brown, et al. were in favour of SV as the primary management for severe AS (although they excluded infants <2 months' age and thus arguably the worst morphology as these all underwent open SV (Table 1) . (20) There was no significant difference in the characteristics of the 2 groups as regards age, body surface area, valve anatomy and gradient. They demonstrated that gradient reduction, aortic incompetence (AI), and the need for re-intervention were worse for BV. Kaplan-Meier analysis at 10 years of SV vs. BV
showed freedom from re-intervention as 72% vs. 53% and freedom from AVR 80% vs. 75%. They concluded that BV has less reduction in gradient, more residual AI, and a shorter interval between subsequent re-interventions than SV. Further they
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SURGICAL VALVOTOMY (SV)
Although surgical aortic valvotomy, transventricular without cardiopulmonary bypass (CPB) or open valvotomy with CPB, was previously perceived as extremely high risk with significant morbidity and mortality, it is now considered to be relatively safe and effective. (32) Absolute indications for surgical management include the need for a single ventricle repair and the presence of additional defects that can only be addressed surgically e.g. small aortic annulus, sub-or supra-valvar aortic stenosis, coarctation, etc. The infant is thus assessed for suitability for a biventricular circulation using various protocols and scoring systems based variously on mitral valve diameter, indexed aortic root diameter, indexed MV area, indexed LV mass, LV inflow structures, morphology of the LVOT, length of the LV, presence and degree of EFE, and functional variables such as reversed flow in the ascending aorta and LV function. (33, 34) None of these scoring systems have proven to be completely accurate.
Predominantly reversed flow in the ascending aorta, particularly associated with decreased LV function, is ominous and a single ventricle repair (palliation) should be considered. In contrast, predominantly prograde flow in the ascending aorta and transverse arch correlates well with survival after a biventricular repair. (27) A small mitral valve orifice is a well-known risk factor for death. (26, 30) Therefore, if the mitral valve annulus diameter is less than 7mm (or less than the -2 z-score), or if there is severe LV inflow obstruction, one should consider a single ventricle palliation, and eventually attempt to promote growth if the rest of the LV is well developed.
In addition, hypoplasia of the aortic annulus (<5mm), a ratio of left to right ventricular lengths of <0.8, a cardiac apex not formed by the LV, and the presence of endocardial fibroelastosis (EFE) are contra-indications for SV (and BV). (25, 26) However, if some of these variables are correctable and biventricular repair is still feasible, the Ross/Ross-Konno operation is an option when the child is older. (25, 28) 
BALLOON VALVULOPLASTY (BV)
In neonates, the aim of BV is to adequately relieve the LVOTO without causing significant AI, and restoring normal LV function. As cardiac catheterisation techniques and equipment have improved, percutaneous balloon valvuloplasty can now be safely performed with little mortality and minimal morbidity and has become the intervention of choice in most centres for severe congenital AS. (38) Neonates with critical AS on alprostadil should be kept sedated and intubated before the BV, to maintain haemodynamic stability during the procedure. In critically ill infants in whom the DA has closed, surgical and ECMO backup should be readily available.
Several methods of arterial accesses for aortic BV have been described over the last 2 decades, although no consensus has been reached as to which is optimal in the neonate. These include retrograde approaches via the femoral artery, the right subscapular artery, the umbilical artery, or the right carotid artery, as well as the prograde transvenous approach through the atrial septum via the foramen ovale. 
Great care must be taken during BV to avoid over-zealous dilation that would result in damage to the aortic valve and subsequent AI. 
McElhinney, et al. found that infants with post-BV AI had a more rapid increase in LVED z-scores at follow-up. (50) Even mild residual AI is a risk factor for progressive AI and ventricular dysfunction and may require earlier AVR. (31, 51) 
AORTIC VALVE REPLACEMENT (AVR)
The majority of patients with severe AS will need further surgery Table 4 ). (52) They suggest further studies to determine long-term outcomes and to better identify candidates for valve repair. At present valve repair is considered for patients with an adequate aortic annulus, without extensive leaflet destruction, and with the potential for a satisfactory result with a minimum of prosthetic material.
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